Stockscreener 앱 받기
37.00
11.69%
-4.90
시간 외 거래:
37.00
전일 마감가:
$41.90
열려 있는:
$38.94
하루 거래량:
48,472
Relative Volume:
1.02
시가총액:
$1.62B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+57.92%
1개월 성능:
+68.18%
6개월 성능:
+342.58%
1년 성능:
+0.00%
1일 변동 폭
$36.00
$44.73
1주일 범위
$21.13
$44.73
52주 변동 폭
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
NNNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
37.00 | 1.79B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
575.34 | 201.58B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.96 | 55.30B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.73 | 38.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
256.55 | 36.71B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
280.23 | 20.27B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Anbio Biotechnology (NNNN) Stock Analysis Report | Financials & Insights - Benzinga
Anbio Biotechnology plummets 56% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria
Anbio Biotechnology trading resumes - MSN
Working capital per share of Anbio Biotechnology Class A – DUS:N3B - TradingView
Anbio Biotechnology rises 15.4% - MSN
Anbio Biotechnology Shares Surge Amid Auditor Appointment - TipRanks
Anbio BiotechnologyClass A Ordinary Shares (Nasdaq:NNNN) Stock Quote | Star Tribune - FinancialContent
Anbio Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting) - 富途牛牛
Anbio Biotechnology Appoints New Auditor - TipRanks
[6-K] Anbio Biotechnology Current Report (Foreign Issuer) | NNNN SEC FilingForm 6-K - Stock Titan
Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK
Anbio Biotechnology trading halted, volatility trading pause - MSN
Medtech test developer Anbio files for $9M US IPO - MSN
Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks
Anbio Biotechnology Shares on a Wild Ride - TipRanks
Anbio Biotechnology falls -19.5% - MSN
Why Anbio Biotechnology Stock is Tumbling - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast & Price Targets: Today, Tomorrow, Next Week - Traders Union
Anbio Biotechnology (NNNN) Stock Price Today | Live Chart & News - Traders Union
Anbio Biotechnology (NNNN) Stock Price Prediction for 2025, 2026, 2030-2040 - Traders Union
Anbio Biotechnology falls -5.5% - MSN
Anbio Biotechnology falls -26.6% - MSN
Why Anbio Biotechnology’s Stock is Tumbling - TipRanks
Anbio Biotechnology (N3B.F) Stock Price, News, Quote & History - Yahoo
Anbio Biotechnology’s Hype And Hard Approvals Suggest A Stretched Valuation (NNNN) - Seeking Alpha
Anbio Biotechnology (N3B.F) Latest Press Releases & Corporate News - Yahoo
Anbio Biotechnology (NNNN) Stock Report: Navigating a Tumultuous Year Amidst a 52-Week Price Fluctuation - DirectorsTalk Interviews
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 - digitalmore.co
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400% - inkl
Anbio Biotechnology rises 40.5% - MSN
Anbio Biotechnology Class A Shares Take a Tumble - TipRanks
White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday - Benzinga
Dow Jumps Over 200 Points; ISM Services PMI Falls In September - inkl
S&P 500 Futures Rise in Premarket Trading; Anbio Biotechnology, Rigetti Computing Lead - Barron's
Anbio Biotechnology Stock Tumbles Amid Volatility - TipRanks
Liverpool Ferry Port Faces Repairs Due to Berth Damage - Berawang News
Jake LaRavia Talks Lakers Role After JJ Redick’s Media Day Insights - Berawang News
Manchester United legend wants Arsenal to win the league – Daily Cannon - Berawang News
Will RSVR stock go up soonJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
What does recent volatility data suggest for GAN Limited2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Ottobock plans 2025 IPO on Frankfurt exchange - BioWorld MedTech
What the charts say about Deswell Industries Inc. todayTrade Volume Summary & Fast Moving Market Watchlists - Newser
Non-operating income, total of Anbio Biotechnology Class A – LSX:A40J71 - TradingView
Visual trend scoring systems applied to Puma Biotechnology Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is AMZE showing signs of accumulationEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
Sentiment Turns Positive on ASGN Incorporated — Reversal AheadWeekly Stock Report & Daily Momentum Trading Reports - beatles.ru
Is Climb Bio Inc. showing signs of accumulation2025 Trade Ideas & High Conviction Investment Ideas - Newser
Are Bears Losing Grip on BLFS? getLinesFromResByArray error: size == 0 - 더경남뉴스
Anbio Biotechnology (NNNN) 재무 분석
Anbio Biotechnology (NNNN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.32%
0.55%
자본화:
|
볼륨(24시간):